Professor, Cardiology, Baylor College of Medicine
Cardiology
Dr. Nasser M. Lakkis, MD
|
|
Give Review
Dr. Nasser M. Lakkis works in the field of Cardiology. He went to medical school at Baylor College of Medicine. He received awards:"Fellow (FACC)". Doctor Nasser M. Lakkis, MD is also published. He has 85 publications published. The lastest publication: "Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Oral Anticoagulation in Atrial Fibrillation.
- Comparison by meta-analysis of percutaneous Coronary intervention versus Coronary artery bypass grafting in patients with a mean age of ≥70 years.
- Application of speckle-tracking in the evaluation of Carotid artery function in subjects with hypertension and diabetes.
- Comparison by Meta-Analysis of Mortality After Isolated Coronary Artery Bypass Grafting in Women Versus Men.
- Usefulness of Speckle Tracking Echocardiography in Hypertensive Crisis and the Effect of Medical Treatment.
- Fibrosing mediastinitis causing ostial Coronary artery compression in a young woman.
- Left Atrial thrombus mimicking a myxoma in a patient with systemic lupus erythematosus.
- New treatment methods for patients with hypertrophic obstructive Cardiomyopathy.
- Comparison of early invasive and conservative strategies in patients with unstable Coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
- Hypertrophic obstructive Cardiomyopathy: alternative therapeutic options.
- Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable Angina and non-ST elevation myocardial in...
- Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic Cardiomyopathy and provocable gradients.
- Comprehensive imaging including three-dimensional echocardiography of an infected, ruptured sinus of valsalva Aneurysm.
- Segmental analysis of Carotid arterial strain using speckle-tracking.
- Platelet inhibition with tirofiban early during percutaneous Coronary intervention: dosing revisited.
- Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients wi...
- Impact of infarct size on clinical and echocardiographic outcome in patients undergoing nonsurgical Septal reduction therapy.
- Impact of adenosine diphosphate and calcium chelation on platelet aggregation testing in patients receiving clopidogrel therapy.
- Massive Pulmonary embolism in pregnancy treated with tissue plasminogen activator.
- Alcohol septal ablation for hypertrophic obstructive Cardiomyopathy: a systematic review of published studies.
- Alcohol relaxes the stiff Heart.
- Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous Coronary intervention and treated with eptifibatide: observations from the ...
- A randomized trial to evaluate the relative protection against post-percutaneous Coronary intervention microvascular dysfunction, ischemia, and inflammation among anti...
- Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation Acute ...
- Usefulness of right ventricular tissue Doppler imaging to predict outcome in left ventricular Heart failure independent of left ventricular diastolic function.
- Impact of aspirin therapy in cancer patients with thrombocytopenia and Acute coronary syndromes.
- Can alcohol Septal ablation normalize systolic function in HOCM?
- Correlation of tissue Doppler and two-dimensional speckle Myocardial velocities and comparison of derived ratios with invasively measured left ventricular filling pres...
- Aspirin and clopidogrel response variability: review of the published literature.
- Comparison of higher clopidogrel loading and maintenance dose to standard dose on platelet function and outcomes after percutaneous Coronary intervention using drug-el...
- Assessment of left ventricular systolic function using echocardiography in patients with preserved ejection fraction and elevated diastolic pressures.
- Usefulness of new diastolic strain and strain rate indexes for the estimation of left ventricular filling pressure.
- Outcome of patients with Acute coronary syndrome admitted to hospitals with or without onsite cardiac catheterization laboratory: a TACTICS-TIMI 18 substudy.
- Early invasive strategy improves outcomes in patients with Acute coronary syndrome with previous coronary artery bypass graft surgery: a report from TACTICS-TIMI 18.
- In vitro inhibition of platelet aggregation in response to increasing concentrations of tirofiban in patients with significant renal insufficiency.
- A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in Coronary ar...
- Persistent left superior vena cava: an incidental finding.
- New, simple echocardiographic indexes for the estimation of filling pressure in patients with cardiac Disease and preserved left ventricular ejection fraction.
- Update on the association of inflammation and Atrial fibrillation.
- Do additional echocardiographic variables increase the accuracy of E/e' for predicting left ventricular filling pressure in normal ejection fraction? An echocardiograp...
- Prognostic implications of elevated troponin in patients with suspected Acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy.
- Reticulated platelets in Acute coronary syndrome: a marker of platelet activity.
- Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation Acute coronary syndrome: the Cl...
- Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes--observations from the TARGET tr...
- Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban.
- Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban.
- Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical Septal reduction therapy for patients with hypertrophic obstructive...
- Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive Cardiomyopathy.
- Platelet glycoprotein IIb/IIIa receptor antagonists and Coronary artery disease.
- Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical Septal reduction therapy in patients with hype...
- Nonsurgical septal reduction therapy for hypertrophic obstructive Cardiomyopathy: one-year follow-up.
- Leukocyte activation with platelet adhesion after Coronary angioplasty: a mechanism for recurrent disease?
- Exercise thallium-201 single photon emission computed tomography for evaluation of Coronary artery bypass graft patency.
- Sodium-dependent retention of prostaglandins in rat ileum.
- Tirofiban for cocaine-induced Coronary artery thrombosis: a novel therapeutic approach.
- Changes in left ventricular filling and left Atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.
- Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing Coronary angioplasty.
- Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive Cardiomyopathy.
- Doppler estimation of left ventricular filling pressures in patients with hypertrophic Cardiomyopathy.
- Echocardiography-guided ethanol septal reduction for hypertrophic obstructive Cardiomyopathy.
- Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive Cardiomyopathy.
- Diagnosis of Coronary artery disease by exercise thallium-201 tomography in patients with a right ventricular pacemaker.
- Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive Cardiomyopathy.
- Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors.
- Safety and efficacy of antiplatelet and antithrombotic therapy in Acute coronary syndrome patients with chronic kidney disease.
- Assessment of the American Society of Echocardiography-European Association of Echocardiography guidelines for diastolic function in patients with depressed ejection f...
- Systolic and diastolic myocardial mechanics in patients with cardiac Disease and preserved ejection fraction: impact of left ventricular filling pressure.
- Usefulness of B-type natriuretic peptide levels to predict left ventricular filling pressures in patients with body mass index >35, 31 to 35, and < or =30 kg/m2.
- A case of Brugada Syndrome presenting with incessant polymorphic ventricular tachycardia.
- Hepatitis C and Carotid atherosclerosis: a retrospective analysis.
- Hypertrophic obstructive Cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
- Role of inflammation in initiation and perpetuation of Atrial fibrillation: a systematic review of the published data.
- The obesity paradox: fact or fiction?
- Comparative cost-effectiveness of B-type natriuretic peptide and echocardiography for predicting outcome in patients with congestive Heart failure.
- Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and Coronary artery disease.
- Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive Heart failure.
- Complete Heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.
- Acute effect of nonsurgical septal reduction therapy on regional left ventricular asynchrony in patients with hypertrophic obstructive cardiomyopathy.
- Use of statins prior to percutaneous Coronary intervention reduces myonecrosis and improves clinical outcome.
- Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with p...
- Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive Heart failure.
- Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive Cardiomyopathy.
- Images in cardiovascular medicine. Avoiding papillary muscle infarction with Myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for...
- Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transCoronary ethanol septal ablation.
Schools
American University of Beirut Faculty of Medicine
Baylor
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Baylor College of Medicine -
American University of Beirut Faculty of Medicine
Hospital
-
Baylor St. Luke's Medical Center
Drug Facts
| NPI NUMBER | 1851471122 | |
| NPPES Provider LastName | LAKKIS | |
| NPPES Provider FirstName | NASSER | |
| NPPES Provider ZIPCode | 770302348 | |
| NPPES Provider State | TX | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1740.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851471122 |
| Last Name Of The Provider | LAKKIS |
| First Name Of The Provider | NASSER |
| View All |
Similar Doctors
|
Dr. Philip L. Berman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard W. Smalling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Virendra S. Mathur, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amin H. Karim, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Francisco R. Maislos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harry R. Gibbs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Poyee P. Tung, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ghassan J. Al-Zaghrini, MD |
|
|
Dr. Alan E. Cororve, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alfredo T. Garcia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gopi A. Shah, MD |
|
|
Dr. Daniel Addison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Salman J. Bandeali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Parag D. Patel, MD |
|
Dr. Iyad N. Daher, MD
This Doctor is OpenDoctor Recommended.
|